awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38569449-490E0BC1-2986-4E02-8DAF-86F8FA091D44
Q38569449-490E0BC1-2986-4E02-8DAF-86F8FA091D44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38569449-490E0BC1-2986-4E02-8DAF-86F8FA091D44
Remogliflozin etabonate: a novel SGLT2 inhibitor for treatment of diabetes mellitus.
P2860
Q38569449-490E0BC1-2986-4E02-8DAF-86F8FA091D44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38569449-490E0BC1-2986-4E02-8DAF-86F8FA091D44
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
732cefac916e6fdb33b2af50e0e56ff698609b43
P2860
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients.